US Stock MarketDetailed Quotes

CRL Charles River

Watchlist
  • 199.590
  • +1.840+0.93%
Close Nov 27 16:00 ET
  • 199.590
  • 0.0000.00%
Post 20:01 ET
10.21BMarket Cap24.92P/E (TTM)

About Charles River Company

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The RMS segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The DSA segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.

Company Profile

SymbolCRL
Company NameCharles River
Listing DateJun 23, 2000
Issue Price16.00
Founded1947
CEOMr. James C. Foster
MarketNYSE
Employees21800
Fiscal Year Ends12-28
Address251 Ballardvale Street
CityWilmington
ProvinceMassachusetts
CountryUnited States of America
Zip Code01887
Phone1-781-222-6000

Company Executives

  • Name
  • Position
  • Salary
  • James C. Foster
  • Chairman of the Board, President and Chief Executive Officer
  • 14.10M
  • Birgit Girshick
  • Chief Operating Officer
  • 4.99M
  • Michael Gunnar Knell
  • Corporate Senior Vice President and Chief Accounting Officer
  • --
  • William D. Barbo
  • Corporate Executive Vice President and Chief Commercial Officer
  • 2.91M
  • Flavia H. Pease
  • Corporate Executive Vice President and Chief Financial Officer
  • 3.81M
  • Victoria L. Creamer
  • Corporate Executive Vice President
  • --
  • Shannon M. Parisotto
  • Corporate Executive Vice President
  • --
  • Joseph W. LaPlume
  • Corporate Executive Vice President, Corporate Development and Strategy
  • 3.06M
  • Reshema Kemps-Polanco
  • Director
  • --
  • Robert J. Bertolini
  • Independent Director
  • 346.02K
  • George Llado, Sr
  • Independent Director
  • 324.77K
  • Dr. Deborah T. Kochevar
  • Independent Director
  • 339.77K
  • Virginia M. Wilson
  • Independent Director
  • 346.02K
  • Richard F. Wallman
  • Independent Director
  • 339.77K
  • Dr. Nancy C. Andrews, M.D.,PhD
  • Independent Director
  • 339.77K
  • Dr. Martin W. Mackay, PhD
  • Independent Director
  • 336.02K
  • George E. Massaro
  • Lead Independent Director
  • 371.02K
  • Dr. Craig B. Thompson,M.D.
  • Independent Director
  • 437.78K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data